1222 budget bill
BioCentury & Getty Images

Politics, Policy & Law

Budget bill extends pediatric priority review vouchers, boosts NIH, FDA

Biopharma companies and PBMs dodged bullets as provisions targeting them were left on the cutting room floor

Dec 22, 2020 | 9:30 PM GMT

Congress has passed an omnibus spending and pandemic relief bill that increases biomedical research funding, funds FDA’s COVID-19 response activities, extends the pediatric priority review voucher program and closes loopholes in the Orphan Drug Act. 

The bill provides a $1.25 billion boost to the NIH budget, including money “to combat foreign threats to research,” as well as modest increases in FDA’s budget targeted to improving the influenza vaccine supply and

Read the full 1100 word article

How to gain access

Continue reading with a
two-week free trial.